Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2007
Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vectorScott E Hensley, Ann S Cun, Wynetta Giles-Davis, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|September 30, 2010
A universal influenza A vaccine based on adenovirus expressing matrix-2 ectodomain and nucleoprotein protects mice from lethal challengeDongming Zhou, Te-Lang Wu, Marcio O Lasaro, et al.Veterinary Microbiology|February 22, 2002
Induction of protective immunity by topic application of a recombinant adenovirus expressing rabies virus glycoproteinCammy Y Lees, Deborah J Briggs, Xianfu Wu, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2012
Hexon-modified recombinant E1-deleted adenovirus vectors as dual specificity vaccine carriers for influenza virusDongming Zhou, Te-Lang Wu, Kristel L Emmer, et al.Virology|August 28, 2010
Neutralizing antibodies to human and simian adenoviruses in humans and New-World monkeysJonatan Ersching, Malva I M Hernandez, Fabrizzio S Cezarotto, et al.Journal of Virology|April 13, 2007
Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectorsKimberly McCoy, Nia Tatsis, Birgit Korioth-Schmitz, et al.Plos Neglected Tropical Diseases|October 30, 2018
A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxisChuan Wang, Pawan Dulal, Xiangyang Zhou, et al.Ebiomedicine|April 25, 2018
Correlates of Protection Against SIVmac251 Infection in Rhesus Macaques Immunized With Chimpanzee-Derived Adenovirus VectorsSteven Tuyishime, Larissa H Haut, Raj K Kurupati, et al.The Lancet. Infectious Diseases|May 1, 2026
Safety and immunogenicity of a single-dose adenovirus-vectored rabies vaccine over 1 year in adults and children in Tanzania: interim data from an ongoing, partly randomised, controlled, phase 1b/2 trialAdam J Ritchie, Omary Hassan, Nsiande Urasa, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|November 18, 2010
Vaccine-induced T cells provide partial protection against high-dose rectal SIVmac239 challenge of rhesus macaquesMarcio O Lasaro, Larissa H Haut, Xiangyang Zhou, et al.Pageof 3